Sanofi reviews

Senior management is inept - perhaps half the VPs are gone but there is more pruning to be done. Sanofi has purchased the company and is trying to sort this out but they seem bewildered by the vast array of problems. Genzyme manufacturing plants were under-managed and under-funded for years and this cannot be turned around overnight. People at all levels are working beneath their position as a way of compensating for a lack of proper management systems.

Management does not seem to know what they are doing day to day as well as overall Top Management making too many changes at the same time without asking for examples or working through real pilot periods where statistics and analysis govern keeping or dumping that strategy Mergers occur without any reassurance for growth Top producers are being lost to other competing companies while the mediocre performers are kept simply because they hold a doctorate degree Quality is suffering due to the numerous and sudden changes in policy and procedure -as soon as the latest policy is adapted another new one is already being rolled out If direct management does know what is going on they do not tell staff or wait until the change is already rolled out which causes mistrust and lack of respect